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Luehea divaricata (Malvaceae) is a plant widely used for treatment of various inflammatory and infectious 
conditions; however few reports discuss its biological properties. The aim of this study was to evaluate 
the anti-inflammatory and analgesic effects as well as the macrophage activity in mice treated with the 
hydroalcoholic crude extract of L. divaricata (CLD). Thin layer chromatography revealed presence of 
epicathequin, stigmasterol, lupeol and α,β-amyrin in the extract. To evaluate the anti-inflammatory and 
analgesic activities, animals were subjected to paw edema induced by carrageenan test, writhing, formalin 
and capsaicin tests. Immunomodulatory activity was evaluated by adhesion and phagocytic capacity, 
lysosomal volume, and reactive oxygen species (ROS) production by peritoneal macrophages, after daily 
treatment with CLD for 15 days. CLD promoted reduction in paw edema (36.8% and 50.2%; p<0.05 
at doses of 100 and 300 mg/kg, respectively), inhibited writhing behavior at the higher dose (64.4%, 
p<0.05), reduced formalin reactivity (81.2% and 91.6% at doses of 100 and 300 mg/kg, respectively, 
p<0.05), and reduced capsaicin reactivity by 63.9% (300 mg/kg). CLD (200 mg·kg-1·day-1) increased 
phagocytosis capacity of macrophages (~3 fold, p<0.05), neutral red uptake (~50%, p<0.001), and ROS 
production (~90%, p<0.001). These data suggest that CLD possesses anti-inflammatory, analgesic and 
immunostimulatory properties.
Uniterms: Luehea divaricata Mart. & Zucc./pharmacognosy. Luehea divaricata Mart. & Zucc./
hydroalcoholic crude extract/properties. Anti-inflammatories. Analgesics. Reactive oxygen species.
Luehea divaricata (Malvaceae) é utilizada para o tratamento de várias condições patológicas, entretanto, 
há poucos relatos sobre sua bioatividade. O objetivo deste estudo foi avaliar o efeito anti-inflamatório 
e analgésico, bem como a atividade de macrófagos em camundongos tratados com extrato bruto 
hidroalcoólico (CLD) da planta. Cromatografia em camada delgada revelou a presença de epicatequina, 
estigmasterol, lupeol e α,β-amirina no material. Para avaliar a atividade anti-inflamatória e analgésica, 
animais foram submetidos a teste de edema de pata induzido por carragenana, teste de contorções, da 
formalina e da capsaicina. A atividade imunomodulatória foi avaliada pela capacidade de adesão e de 
fagocitose dos macrófagos, volume lisossômico e produção de espécies reativas de oxigênio (ROS), após 
tratamento diário com CLD por 15 dias. CLD promoveu redução do edema de pata (36,8% e 50,2%; 
100 e 300 mg/kg, respectivamente; p<0,05), redução do número de contorções (64,4%; 300 mg/kg; 
p<0,05), redução da reatividade no teste da formalina (81,2% e 91,6%; 100 e 300 mg/kg, respectivamente; 
p<0,05), e no teste da capsaicina em 63,9% (300 mg/kg). CLD (200 mg·kg-1·day-1) aumentou capacidade 
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de fagocitose dos macrófagos (~3 vezes, p<0,05), volume lisossômico (~50%, p<0,001) e produção 
de ROS (~90%, p<0,001). Estes dados sugerem que o CLD possui propriedades anti-inflamatórias, 
analgésicas e imunoestimulatórias.
Unitermos: Luehea divaricata Mart. & Zucc./farmacognosia. Luehea divaricata Mart. & Zucc./extrato 
bruto hidroalcoólico/propriedades. Antiinflamatórios. Analgésicos. Espécies reativas de oxigênio.
INTRODUCTION
Luehea divaricata Mart. & Zucc. (Malvaceae) is a 
plant found in the South Region of Brazil and popularly 
known as “açoita-cavalo” by the local inhabitants. Its 
barks have been empirically described by local herbalists 
in Santa Catarina - Brazil to possess antimicrobial and 
anti-inflammatory properties, and it has been used in the 
treatment of respiratory and gastrointestinal infections, 
arthritis, rheumatism, and leukorrhea, and as vermifuge 
(data not published).
Despite the consumption of bark infusions by the 
local population, there is little scientific information 
about its biological activities. Antifungal properties 
have been attributed to a dichloromethane extract of 
L. divaricata barks (25 μg/filter disk), which was able 
to inhibit polymer synthesis or the assembly of the cell 
wall of Neurospora crassa (Zacchino et al., 1998). In 
2003, Brazilian research characterized two triterpenes 
(a tormentic acid derivative and maslinic acid), which 
were obtained from a methanolic extract of L. divaricata 
leaves (Tanaka, Vidotti, Silva, 2003), but the biological 
properties of these compounds have not been assessed. 
The same research group identified a flavonoid, 
epicatechin, from a methanolic extract of the leaves 
of L. divaricata, which demonstrated antimicrobial 
activity against Staphylococcus aureus (250-500 μg/mL) 
(Tanaka et al., 2005). Coelho de Souza et al. (2004) 
also verified the antimicrobial activity of a methanolic 
extract (50 mg/mL) of the aerial parts of L. divaricata. 
Although previous research suggests that L. divaricata 
possesses biological activity, no known studies have 
validated the effectiveness of L. divaricata in the control 
of inflammatory diseases and pain or investigated the 
immunomodulatory capacity of this plant.
Inflammation is a complex process involving a 
network of chemical signals that mediate the actions of 
the immune system. During inflammation, serum proteins 
and leukocytes migrate to areas of tissue injury. These 
inflammatory and activated cells release vasoactive 
mediators such as nitric oxide, bradykinin, and metabolites 
of arachidonic acid, all of which increase regional blood 
flow and promote microvascular permeability (Suffredini 
et al., 1999). Several inflammatory mediators, mainly 
bradykinin and metabolites of arachidonic acid, are 
potent pain-producing agents that can excite and sensitize 
nociceptive primary afferent neurons (Petho, Reeh, 
2012). Several plant extracts have been studied for their 
anti-inflammatory properties, by using in vitro and in 
vivo models (Ojewole, 2006; Siriwatanametanon et al., 
2010; Areej et al., 2013), and existing data suggest that L. 
divaricata may also have similar characteristics.
Apart from anti-inflammatory qualities, natural 
compounds exhibit properties that may interfere with 
the modulation mechanisms of innate immunity, more 
specifically, the function of macrophages (Napolitano 
et al., 2005; Lee et al., 2007; Cruz et al., 2007). Plant 
derivatives present an exciting opportunity for the 
discovery of new therapeutic agents and adjuvants 
that exhibit immunomodulatory properties, potentially 
representing suitable alternatives for the prevention and 
treatment of immune-related pathologies (Kalluf, 2008; 
Tiwari et al., 2004). Plant extracts capable of stimulating 
the immune system might be useful in the treatment and 
prevention of infections. Immunostimulatory effects of 
plant-derived medicines following oral administration 
could be relevant in the search of new-generation vaccine 
adjuvants (Licciardi, Underwood, 2011). On the other 
hand, compounds that exert immunosuppression would 
be desirable in the treatment of autoimmune and chronic 
inflammatory diseases. Studies involving macrophages 
are very significant since they constitute the first line of 
defense of an organism and are responsible for activating 
many other processes involved in immune defense. In 
relation to macrophage functions, plant extracts have been 
shown to reduce nitric oxide production (Mehrotra et al., 
2002; Napolitano et al., 2005), and reduce phagocytosis 
and expression of plasma membrane proteins (Lee et 
al., 2007), as well as stimulate phagocytic capacity and 
production of nitric oxide (Cruz et al., 2007).
To understand the biological potential of L. 
divaricata, the present study aimed to investigate the 
anti-inflammatory, analgesic, and immunomodulatory 
effects of the hydroalcoholic crude extract of L. divaricata 
(CLD) bark in mice. These data are an important starting 
point to characterize the potential biological benefits of 
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L. divaricata and define some of its practical therapeutic 
applications in drug development.
MATERIAL AND METHODS
Animal care
Adult female Swiss mice weighing 25-35 g were 
supplied by the West University of Santa Catarina. The 
animals were maintained in a controlled environment at 
22 °C ± 2 °C with a 12 h light/dark cycle, with free access 
to water and food. All animals were acclimatized to the 
test laboratory 24 h prior to experiments. All procedures 
were approved by the Institutional Ethics Committee of 
West University of Santa Catarina (documents numbers: 
011/2004, 135/2005 and 001/2010) and are in accordance 
with NIH Animal Care Guidelines.
Drugs and reagents
Carrageenan type IV, capsaicin, zymosan, nitroblue 
tetrazolium (NBT), horseradish peroxidase, neutral red, 
phenol red, phorbol myristate acetate (PMA), acetic acid, 
formaldehyde and dimethylsulfoxide (DMSO) were all 
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Plant material and preparation of crude extract
The barks of L. divaricata were collected in March 
2000, in Santa Clara, Joaçaba, Santa Catarina, Brazil 
(geographic coordinates: 27.1758°S, 51.5662°W). The 
specimen was identified with the collection documenting 
number 382.136 at the Municipal Botanical Museum, 
Curitiba-PR, Brazil, and stored at the same local. The 
collected barks of L. divaricata was then dried under 
ventilation in an air-flow chamber and pulverized. The 
powder was submitted to extraction by maceration (25-
30 °C), with ethanol 80° GL for 14 days. The extract was 
filtered and concentrated in a vacuum with a rotatory 
evaporator, until completely dry. The dried extract was 
then stored at -20 °C until use.
Phytochemical analysis
1 g of crude extract of L. divaricata was dissolved 
in 5 mL of ethyl acetate or chloroform. After 5 min, the 
solution was filtered and dried to obtain ethyl acetate 
(SAE) or chloroform (SCHCl3) samples. The yield of 
SAE and SCHCl3 was 2.96% and 6.29%, respectively. 
Both fractions were checked by thin layer chromatography 
(TLC) according Hostettmann, Marston and Hostettmann 
(1998). In order to perform TLC, different eluents and 
systems as mobile phase were used, and silica gel 60 F254 
(Merck) as stationary phase. It was used standards from 
the bank´s laboratory, stigmasterol, lupeol, α,β-amyrin, 
vitexin, rutin, quercetin and epicatechin. Some of these 
compounds were isolated from the plant under study.
The chromatographic SCHCl3 profile was carried 
out with two different solvent systems, hexane:acetone 7:3 
and 8:2, and the standards used were α,β-amyrin, lupeol 
and stigmasterol. The SAE profile was performed with 
chloroform: methanol 8:2, using vitexin, rutin, epicatechin 
and quercetin as standards. In both cases, the spots were 
revealed using sulfuric anisaldehyde to 110 °C and ferric 
chloride.
Paw edema induced by carrageenan test
Experimental animals (n=6-10) were pre-treated 
with the crude extract of L. divaricata (CLD) at doses of 
10-300 mg/kg, orally administered (via oral, v.o.), and 
control animals (n=10) received a vehicle (distilled water; 
0.1 mL/10 g) in place of the CLD. After 1 h, the mice 
were anesthetized with halothane and were administered 
carrageenan (300 mg/paw, subcutaneous injection) 
into the right paw (Morris, 2003). The contralateral 
paw received the same volume of sterile phosphate-
buffered saline (PBS) and served as a control. The paw 
volume was measured with a plethysmometer (Panlab, 
Barcelona, Spain) immediately after carrageenan or PBS 
administration, at specified time points (30, 60, 120, and 
240 min after injection of phlogistic agent). The results 
are expressed as the mean ± standard error of mean (SEM) 
values of the difference in volume (in mililiters) between 
the carrageenan- and saline-treated paws.
Writhing test
Writhing is induced by an intraperitoneal (i.p.) 
injection of acetic acid (0.6%) as an irritant, following 
which writhing movements are observed and evaluated for 
30 min (Koster, Anderson, Debeer, 1959). Experimental 
animals (n=6-10) were pre-treated with the CLD at doses 
of 10 – 300 mg/kg, orally administered (via oral, v.o.) 1 h 
prior to injection of acetic acid. Control animals (n=10) 
received a vehicle (distilled water; 0.1 mL/10 g) in place 
of the CLD. The results are expressed as the mean ± SEM 
of the number of times the animal writhed.
Paw formalin and capsaicin tests
Nociceptive behavior was induced by the injection 
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of formalin (Hunskaar, Hole, 1987) or capsaicin (Sakurada 
et al., 1992) in the ventral surface of the right hind paw. 
Animals (n=6–10) were pre-treated as specified in the 
above-described writhing test. After 1 h of pretreatment 
with CLD or vehicle, the animals received a 20 mL injection 
of either 2.5% formalin solution (0.92% formaldehyde) or 
capsaicin (1.6 µg/paw) prepared in PBS. Following formalin 
or capsaicin injection, the mice were immediately placed 
in glass chambers, and the time spent licking, flicking, and 
biting the injected paw was measured with a stopwatch; this 
time (expressed in seconds) was considered an indication of 
nociception. This nociceptive behavior is recorded in two 
phases for the formalin test and only in the one phase for 
the capsaicin test. The first phase of nociceptive response 
normally peaks at 0-5 min, and the second phase, 15-30 min 
after the formalin injection. The results are expressed as the 
mean ± SEM of nociceptive behavior (in seconds).
Immunostimulatory activity evaluation and 
macrophage isolation
Animals were randomly separated into three groups, 
n=5 animals/group: Control Group, animals received 
only a vehicle (a solution consisting of 10% DMSO and 
40% Tween 80 in saline); Treatment Group 100, received 
100 mg·kg body weight-1·day-1 of CLD; Group 200, received 
200 mg·kg body weight-1·day-1. Body weight was measured 
immediately before administration. All animals were fed a 
regular chow diet (Nuvital®) and received water ad libitum, 
and the treatments with CLD or vehicle were performed by 
gavage daily for 15 days. After this period, the animals were 
sacrificed in a CO2 chamber, and the macrophages were 
collected. This experiment was performed in triplicate such 
that the total number of animals evaluated per group was 15.
Following euthanasia, the resident macrophages 
were obtained after i.p. injection of 5 mL of sterile PBS, 
massaging and opening the peritoneum, and drawing back 
of the fluid with a Pasteur pipette (~5 mL). Macrophages 
were collected by centrifugation (290xg, 4 °C for 5 min), 
the pellet was washed, and then resuspended in PBS after 
counting in a Neubauer chamber by optical microscopy, 
using a Trypan blue solution (1%). Adhesion assay and 
measurement of phagocytic capacity, lysosomal volume, 
superoxide anion production, and hydrogen peroxide 
production were performed using macrophage aliquots 
obtained in this manner.
Adhesion assay
Aliquots (0.1 mL) of macrophage suspension 
(5×106 cells/mL) were added to the wells of a 96-well flat-
bottomed tissue culture plate and left to adhere for 1h under 
controlled temperature (37 °C). After washing with PBS, 
0.15 mL of 50% methanol was added to each well, and 
incubated for 10min at room temperature. The supernatant 
was discarded, and 0.1 mL of 0.2% Giemsa solution was 
added. After incubating at room temperature for 40min, 
washing with distilled water, and incubating with 0.2 mL 
of 50% methanol at room temperature (Rosen, Gordon, 
1987), the absorbance was measured at 550 nm (Microplate 
Reader 680; Biorad®). The mean of adhesion absorbance 
values of each group (C, 100 and 200) was used to normalize 
data for phagocytic capacity, lysosomal volume and ROS 
production assays (normalized value=absorbance value of 
group x/mean of adhesion absorbance of group x). This 
normalization was done to adapt results to the actual number 
of adherent cells on the plate.
Phagocytic capacity
Aliquots (0.1mL) of macrophage suspension 
(2×106 cells/mL) were added to the wells of a 96-well 
flat-bottomed tissue culture plate and left to adhere for 
1h under controlled temperature (37 °C). Then, 10 μL of 
neutral red-stained zymosan (1×108 particles/mL) were 
added to each well. After incubation for 30 min at 37 °C, 
the cells were then fixed with Baker´s formol-calcium 
(4% formaldehyde, 2% sodium chloride, and 1% calcium 
acetate), 0.1 mL/well, for 30 min. The cells were washed 
two times and centrifuged, and then, 0.1 mL of acidified 
alcohol (10% acetic acid, 40% ethanol in distilled water) 
was added to each well (Bonatto et al., 2004). After 30 min 
at 37 °C, the absorbance was measured at 550 nm using 
the microplate reader.
Lysosomal volume
Lysosomal volume was measured using the method 
described by Pipe, Coles and Farley (1995). A macrophage 
suspension (0.1 mL, 1×106 cells/mL) was incubated for 
1 h at 37 °C, and then, 0.02 mL of 2% neutral red solution 
in PBS was added, and the samples were incubated for 
30 min at 37 °C. The cells were washed twice with PBS 
and centrifuged. Neutral red was solubilized with 0.1 mL 
of the extraction solution (1% acetic acid in 50% ethanol) 
(Bonatto et al., 2004). After 30min of incubation at 
37 °C, the absorbance was measured at 550 nm using the 
microplate reader.
Superoxide anion production
Superoxide production was estimated by the NBT 
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reduction assay (Madhavi, Das, 1994). Macrophages 
(0.1 mL) suspended in PBS (2×106 cells/mL) were incubated 
for 1 h at 37 °C in the presence of 0.01 mL of 10 μM phorbol 
myristate acetate (PMA). Subsequently, 0.1 mL of NBT 
solution (0.25%) was added and the samples were incubated 
at 37 °C for 30 min. After centrifugation, cells were fixed 
with 0.1mL of 50% methanol. To assess the amount of 
superoxide anion production by the cells, the formazan 
resulting from NBT reduction was solubilized with 0.12 mL 
of 2 M potassium hydroxide (KOH) and 0.14 mL of 
DMSO. After 30 min of incubation, the absorbance was 
measured at 550 nm using the microplate reader.
Hydrogen peroxide production
Hydrogen peroxide production by macrophages 
was measured as described by Pick and Mizel (1981). 
This assay is based on horseradish peroxidase-dependent 
conversion of phenol red into a colored compound by H2O2. 
Macrophages (0.1 mL, 2×106 cells/mL) were incubated at 
37 °C for 1 h and 10 μM PMA (0.01 mL) was added to 
all the wells. Cells were then incubated in the presence of 
0.1 mL of phenol red solution (5 mM glucose, 0.56 mM 
phenol red, and 8.5 U/mL horseradish peroxidase) in the 
dark for 1h at 37 °C. The reaction was stopped by adding 
0.01 mL of 1 M NaOH, and the absorbance was measured 
at 655 nm using the microplate reader.
Statistical analysis
Data are presented as mean ± standard error of the 
mean (SEM). Statistical analysis was performed by one 
way ANOVA followed by Tukey’s post-hoc test. A P value 
of <0.05 was considered statistically significant.
RESULTS
Phytochemical analysis
Phytochemical analysis by TLC suggested the 
presence of epicatechin in SAE (Figure 1A), and 
stigmasterol, lupeol and α and β-amyrin in the SCHCl3 
(Figure 1B). The other compounds investigated were not 
found.
Anti-inflammatory and analgesic effects
Pretreatment of animals with CLD reduced 
carrageenan-induced edema formation by 36.8% 
and 50.2% at the 100 and 300 mg/kg, respectively 
(Table I, p<0.05). The higher dose of CLD reduced 
FIGURE 1 - Chromatographic profile of L. divaricata. Panel 
A: ethyl acetate fraction (SAE) and E, epicatechin. Panel B: 
chloroform fraction (SCHCl3) (1), stigmasterol (2), lupeol (3) 
and α, β-amyrin (4).
writhing by 64.4% (Table II, p<0.05). Moreover, CLD 
significantly reduced the second phase of formalin 
reactivity (inflammatory phase) by 81.2% and 91.6% 
at 100 and 300 mg/kg, respectively (Table II, p<0.05). 
Capsaicin reactivity was also reduced; the time spent on 
painful activities was reduced by 63.9% in animals that 
received the higher dose of CLD (Table II).
Adhesion capacity
Animals that received 200 mg/kg of CLD (Group 
200) significantly reduced macrophage adhesion 
compared to both the Control Group and Group 100 
(~55%, p <0.05). Group 100 showed similar adhesion 
capacity to the Control Group (p >0.05) (Figure 2).
Phagocytic capacity
Macrophages from Group 200 showed ~3-fold 
increased phagocytic capacity than the Control Group 
(p <0.001) and Group 100 (p <0.001). There was no 
significant difference between the Control Group and 
Group 100 (p >0.05) (Figure 3).
Lysosomal volume
Neutral red uptake by the macrophages in Group 200 
was ~50% greater than that observed to the Control Group 
(p <0.001), which was in contrast to the macrophages from 
Group 100, which showed a reduction of uptake capacity 
by ~20%. Group 200 presented ~90% higher uptake 
capacity than Group 100 (p <0.001, Figure 4).
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TABLE I - Anti-inflammatory effect of crude extract of L. divaricata (CLD) on the paw edema induced by carrageenan test in mice 
Groups Dose mg/kg
Paw edema induced by carrageenan (300 mg/paw) measured with 
plethysmometer at different time points Edema 
inhibition (%)
30 min 60 min 120 min 240 min
Control  distilled water 32.5 ± 6.1 62.5 ± 6.3 112.5 ± 13.1 120.0 ± 15.8 0.0
Crude Extract
10 33.3 ± 6.7 46.6 ± 4.2 71.6 ± 7.3 96.6 ± 6.7 27.3
30 31.6 ± 8.7 43.3 ± 5.5 80.0 ± 10.6 106.6 ± 8.0 21.8
100 18.0 ± 4.8 34.0 ± 8.1a 62.0 ± 10.6a 94.0 ± 7.5a 36.8
300 4.0 ± 2.4a 24.0 ± 7.4a 60.0 ± 13.8a 64.0 ± 8.1a 50.2
Each group represents the mean for 6 to 10 animals. Significantly different from control group: a p <0.05. Results are presented 
as mean ± EPM values of the difference in volume (mL) between the carrageenan- and saline-treated paws. The edema inhibition 
was determined by calculating the area under curve.
TABLE II - Analgesic effect of crude extract of L. divaricata (CLD) on the writhing test, paw formalin test and paw capsaicin test 
in mice 
Models Control
Dose of CLD (mg/kg)
10 30 100 300
Writhing test number of writhings 35.4 ± 4.1 26.0 ± 3.4 26.6 ± 1.6 25.0 ± 4.1 12.6 ± 4.4a
Paw formalin test 1st fase (seconds) 57.0 ± 7.7 62.3 ± 7.3 41.3 ± 3.1 51.8 ± 14.5 50.6 ± 11.2
2nd fase (seconds) 76.0 ± 16.4 51.3 ± 13.3 37.8 ± 14.1 14.3 ± 8.2a 6.4 ± 4.0a
Paw capsaicin test Reactivity (seconds) 26.6 ± 3.0 30.3 ± 4.6 27.0 ± 2.2 9.6 ± 2.1a n.d.
Each group represents the mean ± SEM for 6 to 10 animals. Significantly different from control group: a p <0.05. n.d., not determined. 
The time in seconds indicates time spent licking, flicking, and biting the injected paw. 
FIGURE 2 - Adhesion capacity of resident macrophages from 
mice fed regular chow (Control Group), treated with 100 mg/kg 
b.w. of CLD (Group 100), and 200 mg/kg b.w. (Group 200). a 
p<0.05 compared to Control. b p<0.05 compared to Group 100. 
Results are presented as % relative to Control.
FIGURE 3 - Phagocytic capacity of resident macrophages 
from mice fed regular chow (Control Group), treated with 
100 mg/kg b.w. of CLD (Group 100), and 200 mg/kg b.w. 
(Group 200). a p<0.001 compared to Control. b p<0.001 
compared to Group 100. Results are presented as % relative to 
Control.
Reactive oxygen species (ROS) production
Superoxide anion (Figure 5) and hydrogen 
peroxide (Figure 6) production was ~90% greater in the 
macrophages from Group 200 than those from the Control 
Group (p <0.001). The macrophages from Group 100 
produced half the concentration of ROS compared to that 
of Group 200 (p <0.001). No statistical difference was 
observed between the Control Group and Group 100.
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DISCUSSION
Bioactive compounds found in medicinal plants 
may present anti-inflammatory and analgesic capacities, 
in addition to immunomodulation properties. Indeed, 
many compounds isolated from plant extracts have 
demonstrated anti-inflammatory properties as well as 
immunostimulatory activities (da Silva, Parente, 2001; 
Biella et al., 2008; Halder et al., 2009). The current study 
characterizes the biological activity of L. divaricata bark 
for the first time, specifically showing that CLD reduced 
inflammation in all assays performed and that it stimulated 
macrophage activity.
Thin layer chromatography (Figure 1) revealed the 
presence of epicatechin in the SAE, and stigmasterol, 
lupeol and α and β-amyrin in the SCHCl3. Whereas some 
flavonoids and triterpenes exhibit immunomodulatory and 
anti-inflammatory activities (Saleem, 2009; Sabeva et al., 
2011; Ahmad et al., 2013; Rosenblat, Volkova, Aviram, 
2013), it is possible that they may be partly responsible 
for the activities found in the present study.
Carrageenan-induced paw edema is a well-
characterized experimental model of inflammation, and 
it has been widely used to investigate the efficacy of 
natural compounds (Nardi et al., 2003; Wang et al., 2013). 
The acute inflammatory reaction elicited by carrageenan 
is characterized by sequential liberation of inflammatory 
mediators, promoting marked accumulation of exudate 
and intense migration of polymorphonuclear leukocytes 
in the affected paw (Morris, 2003). In the present study, 
we clearly show the anti-inflammatory properties of CLD, 
as demonstrated by a dose-dependent reduction in paw 
edema in mice (Table I). This effect was evident 30 min 
after the oral administration of CLD, and was maintained 
throughout the evaluation period.
The writhing test is an experimental model used 
to screen investigational drugs for analgesic activity. 
This is evaluated by the irritation caused by the i.p. 
injection of acetic acid, which causes the release of 
mediators such as bradykinin, prostaglandins, histamine, 
and 5-hydroxytryptamine (Whittle, 1964). Different of 
writhing test, in formalin test is possible to identify two 
phases of nociception. The first phase is characterized by 
direct activation of primary afferent fibers, followed by 
the second phase, which is characterized by the release 
of several inflammatory mediators in the immediate area 
of formalin injection (Hunskaar, Hole, 1987; Corrêa, 
Calixto, 1993; Choi, Lee, Suh, 2001). The CLD effectively 
reduced writhing behavior that suggests a level of pain in 
animals (Table II). This reduction in pain by CLD is further 
supported by the reduction in pain, as demonstrated in the 
FIGURE 4 - Lysosomal volume of resident macrophages 
from mice fed regular chow (Control Group), treated with 
100 mg/kg b.w. of CLD (Group 100), and 200 mg/kg b.w. 
(Group 200). a p<0.001 compared to Control. b p<0.001 
compared to 100. Results are presented as % relative to control.
FIGURE 5 -  Superoxide anion production of resident 
macrophages from mice fed regular chow (Control Group), 
treated with 100 mg/kg b.w. of CLD (Group 100), and 
200mg/kg b.w. (Group 200). a p<0.001 compared to Control. b 
p<0.001 compared to 100. Results are presented as % relative 
to control.
FIGURE 6 - Hydrogen peroxide production of resident 
macrophages from mice fed regular chow (Control Group), 
treated with 100 mg/kg b.w. of CLD (Group 100), and 
200 mg/kg b.w. (Group 200). a p<0.001 compared to Control. b 
p<0.001 compared to 100. Results are presented as % relative 
to control.
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second phase of formalin test for CLD-treated animals 
(Table II). The lack of effect of CLD in the first phase 
of the formalin test supports our hypothesis that anti-
inflammatory substances are responsible for the analgesic 
effect of CLD, rather than a direct excitation of the primary 
afferents.
Capsaicin is known to directly activate the vanilloid 
receptor (TRPV-1) in the primary afferent fibers, which 
transmits the nociceptive stimulus to the central nervous 
system, promoting the release of pro-inflammatory 
neuropeptides such as substance P, neurokinins, nitric 
oxide, and prostaglandins. These substances are responsible 
for producing the sensation of pain and inflammatory 
process (Holzer, 1991; Wu et al., 1998; Palazzo, Rossi, 
Malone, 2008). The data on formalin test paired with the 
reduction in capsaicin-induced pain behavior suggests that 
CLD activity is due to the modulation of inflammatory 
mediators. Together with the reduction in edema in the 
carrageenan model, these data suggest that CLD contains 
anti-inflammatory substances, which act to reduce the 
sensation of pain by reducing inflammatory excitation of 
nociceptors in the primary afferent fibers.
Indigenous populations who use crude extract 
of L. divaricata to treat various conditions prepare 
infusions of the barks that are often administered orally. 
To simulate the effects of oral intake and evaluate the 
potential immunomodulatory activity of CLD, we orally 
administered CLD to animals for 15 days. According to 
Gertsch, Viveros-Paredes and Taylor (2011), the activity of 
the immune system can only unambiguously be evaluated 
in vivo, and the most ethnopharmacologically relevant 
way to test plant products is by oral administration. Here, 
we show that oral administration of a minimum of 200 
mg/kg CLD produced an overall stimulatory effect on the 
peritoneal macrophages from mice.
The adhesion capacity of the macrophages from 
Group 200 was reduced by ~50% in comparison to those 
from both the Control Group and Group 100 (Figure 2). 
Modifications in the adhesion capacity of cells can be 
derived from changes in either the membrane fluidity 
(Calder et al., 1990; Noudeh et al., 2010) or in the 
distribution of adhesion molecules within the plasma 
membrane (KyungSeop et al., 2000; Kim et al., 2011). 
For example, there are reports showing that polyphenols 
and tannins contained in plant extracts are able to modify 
the properties of the plasma membrane, thereby affecting 
adhesion capacity (Cyboran, Oszmianski, Lkeszczynska, 
2012; Olchowik et al., 2012). Interestingly, the phagocytic 
capacity observed in Group 200 was 3-fold greater than 
that observed for Control Group (p<0.001) (Figure 3). This 
measurement was normalized by adhesion capacity, and 
although the adhesion capacity of the cells in Group 200 
was 50% lower than that observed for the Control Group, 
the phagocytic capacity of adherent cells was still 3-fold 
greater. Together, these data indicate that the substances 
present in the barks of L. divaricata are able to stimulate 
a significant macrophage-mediated response, contributing 
to the body of evidence demonstrating that plant 
components influence immunomodulation by altering 
the phagocytic capacity of macrophages (Bin-Hafeez et 
al., 2003; Lee et al., 2007; Cruz et al., 2007) and other 
phagocytic cells (Nudo, Catap, 2011). However, a dose 
of 100 mg/kg did not elicit an impact on the adhesion and 
phagocytic capacity of isolated macrophages, suggesting 
an insufficient concentration of bioactive molecules to 
provide immunomodulation. Notwithstanding the lack of 
response in Group 100, the results obtained in the current 
study, particularly in relation to phagocytosis modulation, 
suggest that CLD is able to strongly stimulate the innate 
immune system at sufficient concentrations.
Cellular digestion of agents contained in phagosomes 
is controlled by fusion to hydrolase-containing lysosomal 
vesicles. Neutral red uptake by macrophages in Group 
200 was greater than that observed in Group 100 and the 
Control Group (Figure 4). This supports the dose-dependent 
response observed in phagocytic capacity (Figure 3), 
indicating that the cells were able to both phagocytose 
the cationic dye neutral red and process it. However, the 
lysosomal volume of Group 200 did not show a proportional 
increase in neutral red uptake with respect to phagocytic 
capacity. This mismatch between phagocytosis and dye 
uptake has also been observed by other research groups 
(Bonatto et al., 2004). Swanson and Baer (1995) report 
that several events enable fusion between the lysosomal 
vacuolar membrane and phagosomes, which together 
form a phagolysosome. The rate of phagosome-lysosome 
fusion can vary dramatically depending on the nature of 
the encapsulated particles, suggesting that not all particles 
phagocytized stimulate a large change in lysosomal volume. 
This may partly explain the disparity between the results 
obtained for phagocytic capacity (Figure 3) and lysosomal 
volume (Figure 4) in Group 200.
Resting macrophages consume little oxygen, 
although activation by an appropriate stimulus leads 
to increased production of reactive oxygen species 
(ROS). ROS are produced by macrophages (superoxide 
anions and hydrogen peroxide) by a non-mitochondrial 
respiratory burst, which greatly increases consumption 
of oxygen and conversion to superoxide anions (Babior, 
1984). The nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH oxidase) enzyme that resides in the 
plasma membrane of phagocytes is responsible for this 
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conversion, and it is activated by phagocytosis as well as 
by compounds such as PMA via activation of kinase C 
proteins (Lunardi, Lima, 2006). Superoxide anions and 
hydrogen peroxide that are immediate products of this 
respiratory burst lead to the generation of hypochlorite 
and chloramines, which are potent microbicidal oxidized 
halogens, in addition to hydroxyl radicals, an oxidizing 
radical that can damage all types of macromolecules 
(Babior, 1984). Our results show an increase in the 
concentrations of superoxide anion and hydrogen peroxide 
produced by the activated macrophages from Group 200 
in comparison to those from Control Group (Figure 5 and 
Figure 6). These data are consistent with the increased 
phagocytic capacity of the macrophages from Group 
200 animals. In these experiments, the cells of all groups 
were treated with PMA, but a greater concentration of 
superoxide anions and hydrogen peroxides were observed 
in Group 200 compared to Group C, suggesting that the 
crude extract at 200 mg/kg was able to stimulate the 
production of these ROS by macrophages. Studying the 
molecular mechanisms by which the compounds from 
CLD stimulate ROS production in macrophages was not 
the aim of this study, but we found that the crude extracts 
from medicinal plants are able to interact directly on the 
NADPH oxidase enzyme (Mahomoodally et al., 2012), 
suggesting that this action of the extract on this enzyme 
cannot be ruled out. Physiologically, the activation 
of phagocytic NADPH oxidase can be induced by 
microbial products such as bacterial lipopolysaccharide, 
by lipoproteins, or by cytokines such as interferon-γ, 
interleukin-1β, or interleukin-8 (Bonizzi et al., 2000). 
In addition to exerting an important role as microbicidal 
agents, superoxides and related ROS contribute to signal 
transduction via various membrane receptors, and thus, to 
overall immunological function (Drogë, 2002).
Taken together, these results indicate that the CLD 
contains substances with both anti-inflammatory and 
analgesic effects, as well as immunomodulatory bioactive 
compounds capable of stimulating macrophage activity. 
These findings support the empirical use of this plant 
to combat different types of inflammatory diseases and 
infections. Further studies are necessary to elucidate the 
chemical compounds within CLD that contribute to these 
properties, and to evaluate the therapeutic effects exerted 
by these compounds on adaptive immune cells and their 
products.
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